ANIP
NASDAQ · Pharmaceuticals
Ani Pharmaceuticals Inc
$67.79
-1.83 (-2.63%)
Open$68.99
Previous Close$69.62
Day High$70.96
Day Low$67.73
52W High$95.57
52W Low$68.79
Volume—
Avg Volume420.4K
Market Cap1.60B
P/E Ratio14.77
EPS$5.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-45.8% upside
Current
$67.79
$67.79
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 981.67M | 697.16M | 587.23M |
| Net Income | 87.06M | 55.64M | 76.98M |
| Profit Margin | 8.9% | 8.4% | 13.1% |
| EBITDA | 225.05M | 151.83M | 125.34M |
| Free Cash Flow | — | — | 59.62M |
| Rev Growth | +40.8% | +40.8% | +23.0% |
| Debt/Equity | 1.14 | 1.14 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |